Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines

被引:54
作者
Zhao, HJ
Kim, Y
Wang, P
Lapointe, J
Tibshirani, R
Pollack, JR
Brooks, JD
机构
[1] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
关键词
androgen; microarray; aCGH; tumor subtypes; metastasis; prostate cancer cell lines;
D O I
10.1002/pros.20158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. The aim of this study was to characterize gene expression and DNA copy number profiles in androgen sensitive (AS) and androgen insensitive (AI) prostate cancer cell lines on a genome-wide scale. METHODS. Gene expression profiles and DNA copy number changes were examined using DNA microarrays in eight commonly used prostate cancer cell lines. Chromosomal regions with DNA copy number changes were identified using cluster along chromosome (CLAC). RESULTS. There were discrete differences in gene expression patterns between AS and AI cells that were not limited to androgen-responsive genes. AI cells displayed more DNA copy number changes, especially amplifications, than AS cells. The gene expression profiles of cell lines showed limited similarities to prostate tumors harvested at surgery. CONCLUSIONS. AS and AI cell lines are different in their transcriptional programs and degree of DNA copy number alterations. This dataset provides a context for the use of prostate cancer cell lines as models for clinical cancers. (c) 2004 Wiley-Liss, Inc.
引用
收藏
页码:187 / 197
页数:11
相关论文
共 30 条
[1]  
Amler LC, 2000, CANCER RES, V60, P6134
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   Androgen receptor expression in prostate carcinoma cells suppresses α6β4 integrin-mediated invasive phenotype [J].
Bonaccorsi, L ;
Carloni, V ;
Muratori, M ;
Salvadori, A ;
Giannini, A ;
Carini, M ;
Serio, R ;
Forti, G ;
Baldi, E .
ENDOCRINOLOGY, 2000, 141 (09) :3172-3182
[4]   Androgen receptor and prostate cancer invasion [J].
Bonaccorsi, L ;
Muratori, M ;
Carloni, V ;
Zecchi, S ;
Formigli, L ;
Forti, G ;
Baldi, E .
INTERNATIONAL JOURNAL OF ANDROLOGY, 2003, 26 (01) :21-25
[5]   CHROMOSOME IDENTITY OF HUMAN PROSTATE-CANCER CELL-LINES, PC-3 AND PPC-1 [J].
CHEN, TR .
CYTOGENETICS AND CELL GENETICS, 1993, 62 (2-3) :183-184
[6]   Role of the androgen receptor axis in prostate cancer [J].
Culig, Z .
UROLOGY, 2003, 62 (5A) :21-26
[7]  
DePrimo SE, 2002, GENOME BIOL, V3
[8]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[9]  
Gregory CW, 2001, CANCER RES, V61, P2892
[10]   Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance [J].
Holzbeierlein, J ;
Lal, P ;
LaTulippe, E ;
Smith, A ;
Satagopan, J ;
Zhang, LY ;
Ryan, C ;
Smith, S ;
Scher, H ;
Scardino, P ;
Reuter, V ;
Gerald, WL .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :217-227